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Malaria is a protozoal disease transmitted by
the Anopheles mosquito, caused by minute parasitic
protozoa of the genus Plasmodium, which infect
human and insect hosts alternatively. It affects over
40% of the worldís population, with 120 million
cases reported, and about 2 million deaths annually
(1). The P. falciparum variety of the parasite
accounts for 80% of cases and 90% of deaths caused
by malaria. The declining efficacy of classical med-
ication in relation to the rapid increase of parasite
resistant strains, mainly of Plasmodium falciparum,
as well as the greater resistance of vectors to insec-
ticides, and the difficulty of creating efficient vac-
cines have led to an urgent need for new efficient
antimalarial drugs (2, 3). Natural molecules may
provide innovative strategies towards malarial con-
trol, hence active research groups are now working
to develop new active compounds as an alternative
to chloroquine, especially from artemisinin (4, 5), a
plant-based antimalaria drug isolated from the
Chinese plant Artemisia annua (6). Plants may well,
therefore, prove to be the sources of new antimalar-
ial in view of the success with the two important
chemotherapeutic agents, quinine and artemisinin,
both of which are derived from plants.
Cleome rutidosperma (Capparidaceae) is a
low-growing herb, up to 70 cm tall, found in waste
grounds and grassy places with trifoliate leaves and
small, violet-blue flowers, which turn pink as they
age. The elongated capsules display the asymmetri-
cal, dull black seeds. The plant is native to West
Africa, although it has become naturalized in vari-
ous parts of tropical America as well as Southeast
Asia (7, 8). The diuretic, laxative, anthelmintic,
antimicrobial, analgesic, anti-inflammatory,
antipyretic, antioxidant and free radical scavenging
activities of Cleome rutidosperma were reported ear-
lier by the authors (9-13). The plant is used as anti-
malarial by the traditional healers in Cameroon and
mild antiplasmodial activity of chloroform/methan-
ol (1:1) extract of leaves of Cleome rutidosperma
against chloroquine-sensitive (F32) laboratory strain
of P. falciparum was reported earlier in Cameroon
(14). The present study investigates the in vitro
antiplasmodial activity of ethanolic extract and its
fractions of aerial parts of Cleome rutidosperma
against the chloroquine sensitive (CQS) D10 strain




The plant material (whole plant) was collected
from North 24-Pargana district of West Bengal, India
during September 2004 and was authenticated at
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Botanical Survey of India, Shibpur, Howrah, West
Bengal, India. A voucher specimen (C.R.-1) has
been kept in our research laboratory for future refer-
ence. The fresh aerial parts were washed under run-
ning tap water to remove adhered dirt, followed by
rinsing with distilled water, shade dried and pulver-
ized in a mechanical grinder to obtain coarse powder.
Preparation of extracts
The aerial parts were extracted with 90%
ethanol using Soxhlet apparatus. The solvent was
removed under reduced pressure, which gave a
greenish-black colored sticky residue (yield 11.6%
w/w on dried material basis). A portion of dried
ethanolic extract was suspended in water and frac-
tionated successively with petroleum ether (40-
60∞C), diethyl ether, ethyl acetate and n-butanol. All
the fractions were dried by distillation under
reduced pressure and kept in a desiccator until used.
For preparation of aqueous extract, 50 g of pow-
dered aerial parts were stirred in 450 mL of boiling
distilled water. Boiling was allowed to continue for
5 min. The mixture was then kept aside for 30 min
to allow it to infuse. It was then filtered initially with
cloth filter then with filter paper, evaporated and
dried under reduced pressure to yield solid residue,
which was kept in a desiccator until used. 
In vitro antiplasmodial activity
Continuous in vitro culture of asexual erythro-
cyte stages of Plasmodium falciparum were main-
tained using a modified method of Trager and
Jensen (15). Quantitative assessment of antiplas-
modial activity in vitro was determined via the para-
site lactate dehydrogenase (pLDH) assay using a
modified method described by Makler (16). The
pLDH assay compares well with other available
assays (17). The fractions were tested in duplicate
against the chloroquine sensitive (CQS) D10 strain
of the parasite. The fractions were dissolved in 10%
methanol or 10% DMSO and stored at -20OC until
use. The fractions were tested as a suspension if not
properly dissolved. The highest concentration of
solvent to which the parasites were exposed had no
measurable effect on the parasite viability.
Chloroquine (CQ) was used as the reference drug in
all experiments. The starting concentration of the
full dose-response experiment was 100 µg/mL,
which were serially diluted 2-fold in complete medi-
um to give 10 concentrations, with the lowest con-
centration being 0.195 µg/mL. CQ was tested at an
initial concentration of 100 ng/mL. The same dilu-
tion technique was used for the other samples. The
50% inhibitory concentration (IC50) values were
obtained using a non-linear dose-response curve fit-
ting analysis via GraphPad Prism v.4.0 software.
Cytotoxicity test on mammalian cells
The most potent extract fraction (diethyl ether
fraction) was evaluated for in vitro cytotoxicity
against a mammalian cell-line, Chinese Hamster
Ovarian (CHO) using the 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT)-assay.
The MTT-assay is used as a colorimetric assay for
cellular growth and survival, and compares well
with other available assays (18, 19). The tetrazolium
salt MTT was used to measure both growth and
chemosensitivity. The sample was dissolved in 10%
methanol and tested as a suspension. The initial con-
centration of stock solutions was 2 mg/mL for all
samples. Samples were stored at -20OC until use.
The highest concentration of solvent to which the
cells were exposed had no measurable effect on the
cell viability. Emetine was used as the reference
drug in all experiments. The initial concentration of
emetine was 100 µg/mL, which was serially diluted
in complete medium with 10-fold dilutions to give 6
concentrations, the lowest being 0.001 µg/mL. The
same dilution technique was applied to the test com-
pounds with an initial concentration of 100 µg/mL,
to give 5 concentrations, with the lowest concentra-
tion of 0.01 µg/mL. All samples were tested in trip-
licate on a single occasion. The 50% inhibitory con-
centration (IC50) values for these samples were
obtained from dose-response curves, using a non-
linear dose-response curve fitting analyses via
GraphPad Prism v.4 software.
RESULTS AND DISCUSSION
The IC50 values obtained from the tests on the
CQS D10 strain of Plasmodium falciparum are
shown in Table 1. The selectivity index (SI), defined
as the ratio of cytotoxicity to antiplasmodial activity
and determined by dividing the IC50 values for the
CHO cells by the IC50 value for Plasmodium falci-
parum is also shown for the most active fraction
(Table 2). High selectivity (high SI values) indicates
potentially safer therapy of the drugs against malar-
ia parasite. 
Evaluation of in vitro antiplasmodial activity of
ethanolic extract of Cleome rutidosperma showed
moderate activity against P. falciparum CQS D10
strain (IC50 value of 34.4 µg/mL), although the aque-
ous extract was found to be inactive (IC50 > 100
µg/mL). Fractionation process enhanced the activity
of the initial crude ethanolic extract, whereas petro-
leum ether and diethyl ether fractions were found to
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be more active than the main ethanolic extract. As
the ethanolic extract and its fractions were fairly
insoluble, even in DMSO and were tested as a sus-
pension, this might have affected the accuracy of the
results and the actual IC50 values might be even
lower. The diethyl ether fraction was found to be the
most potent fraction and showed good antiplasmodi-
al activity with IC50 value of 8.1 µg/mL. The fraction
did not show any cytotoxicity against the CHO cell-
line at the concentrations tested. This indicated the
activity selectivity for the tested parasite. 
The presence of phytoconstituents like ter-
penoids or flavonoids have been previously found to
be responsible for antimalarial activities in plants
(20-28). The presence of these constituents in
ethanolic extract and its potent fractions of Cleome
rutidosperma, as reported earlier (13), may be
responsible for the observed activities.
Investigations are in progress to identify the active
antimalarial compounds of Cleome rutidosperma by
bioassay-guided fractionation.
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Table 1. In vitro antiplasmodial activity of Cleome rutidosperma
against P. falciparum CQS D10 strain.
Treatment IC50
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Diethyl ether fraction of E* 8.1 µg/mL
Ethyl acetate fraction of E* 54.3 µg/mL
n-Butanol fraction of E* 76.4 µg/mL
Water extract > 100 µg/mL
Chloroquine 11.1 ng/mL (n = 3)
*Tested as a suspension. Values are the average of three replicates.
n = number of data averaged.







> 100 > 12.3
Emetine 0.05
Values are the average of three replicates. 
aSelectivity index (SI) = cytotoxicity IC50 / antiplasmodial IC50
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